A DOPA scan, also called a DaTscan, is a SPECT imaging test that uses a small radioactive tracer to show dopamine transporter activity in the brain’s striatum. It helps identify presynaptic dopamine loss and distinguish Parkinsonian syndromes from essential tremor. The scan shows patterns and levels of dopamine uptake but is one component of clinical diagnosis, not definitive alone.

A dopamine brain scan uses nuclear imaging (SPECT or PET) and a radioactive tracer to visualize dopamine-producing neurons, dopamine transporters, or receptors in the brain. Common tests (e.g., DaT-SPECT or PET with F‑DOPA) help diagnose Parkinsonian syndromes, distinguish tremor causes, and assess dopamine function in research. The scan requires tracer injection, involves small radiation exposure, and aids diagnosis and treatment.

Costs vary widely by test type and country. In publicly funded systems it’s typically covered; privately in the US it may cost roughly $1,000–3,000 without insurance. In India private centers commonly charge a few thousand to tens of thousands of rupees depending on facility and radiotracer. Always check your local hospital or lab for exact pricing and insurance coverage.

Dopa PET scans are generally safe. Side effects are uncommon and usually mild: injection-site pain, bruising or redness; headache, nausea or dizziness; rare allergic reactions to the tracer; feeling of warmth or discomfort from lying still and possible claustrophobia. The scan exposes you to a small amount of ionising radiation, so pregnancy and breastfeeding require special precautions.

L‑DOPA crosses the blood–brain barrier and is converted into dopamine, restoring depleted dopamine levels in the basal ganglia. This improves motor control and reduces Parkinsonian bradykinesia and rigidity, while affecting mood and reward circuits. Increased synaptic dopamine can cause side effects such as dyskinesias, motor fluctuations, nausea, orthostatic hypotension and psychiatric symptoms (hallucinations, confusion) with long-term use.

A dopamine transporter (DAT) SPECT scan — commonly called a DaTscan (I‑123 ioflupane) — is used to detect loss of dopamine transporters in the striatum and support a Parkinson’s diagnosis. Structural MRI helps rule out other causes, while PET scans can also show dopaminergic deficits. Imaging supports clinical assessment but does not definitively confirm Parkinson’s disease.